Funding & Investment

Four portfolio companies of Oridian Capital Partners land on Inc. 5000's fastest-growing lists, revealing a potent strategy for scaling middle-market firms.

Money20/20 elevates its global awards with a powerhouse jury, aiming to set the definitive benchmark for fintech excellence. What does this mean for the industry?

Stratom's new TRAILS system will let Marines rapidly move 10,000-lb payloads under fire, boosting survivability in future conflicts.

With a new fund and a key hire, the PE firm signals an aggressive push to dominate the burgeoning market for AI and cybersecurity infrastructure services.

Clarivoy appoints TrueCar veteran Molly Kristick to a new CXO & CMO role, signaling a strategic shift to merge marketing with the total client experience.

A stunning Q1 2026 revival shows SPACs are not dead. Fueled by veteran sponsors and a focus on AI and defense, a new era for public listings may be dawning.

With a new CFO from Snap and a VP of Revenue from Shopify, Route is scaling up to dominate the lucrative post-purchase market for large retailers.

A landmark report reveals a crisis: 91% of biopharma firms lack the data maturity for AI, undermining patient care and stalling innovation.

More than 100 nonprofits receive funding in a global initiative tackling food security, mental health, and more, powered by employee involvement.

The overnight oats giant expands to 36,000 stores, tapping into America's protein craze with new products and key partnerships with Starbucks and Target.

Cookeville wealth firm Cravens & Company Advisors hires a CFA charterholder as Director of Investments and promotes an analyst in a strategic expansion.

As stress hits critical levels, one wellness company is betting that high-tech recovery and a new mindset can redefine self-care for a new generation.

Former Biosynth CEO Dr. Urs Spitz joins Ribbon Bio, signaling a major push to commercialize its groundbreaking cell-free DNA synthesis platform.

Saudi Arabia's Jood Eskan platform blends Islamic principles with digital efficiency, raising billions to house thousands and setting a new global standard.

With $80B in AUM, Pzena launches its first active ETFs. Can its classic value approach stand out in the booming, competitive ETF marketplace?

A new holding company from Rise8's founder offers an alternative to VC, aiming to scale mission-critical software without sacrificing founder autonomy.

The leading health system is deploying Midstream Health's AI agents to tackle operational costs and secure long-term financial sustainability.

With millions more pilgrims, a 'super-app' in every hand, and mega-projects underway, Saudi Arabia is engineering the future of Umrah and Hajj.

FDA approves a pivotal trial for a novel heart valve, potentially revolutionizing treatment for millions with severe tricuspid regurgitation.

A new IDC MarketScape report positions HighByte as a leader in the emerging Industrial DataOps space, validating its pivotal role in manufacturing's AI future.